HOME >> BIOLOGY >> NEWS
Protein essential for making steroids turns out to be a "molten globule"

he body," Miller said. "Hormone replacement therapy can save their lives, but the children also must receive mineralcorticoid and glucocorticoid replacements throughout their lives to help maintain salt and sugar balance."

Miller's lab has been working in cooperation with Michael Baldwin, PhD, and Thomas James, PhD, in the department of pharmaceutical chemistry at UCSF to determine the structure of StAR and learn how it works.

Miller credits Bose, a postdoctoral fellow with a background in physical chemistry, for enlisting help from Baldwin, James and other UCSF experts in protein spectroscopy to study how the StAR protein is folded into its final shape. Most proteins are not active in this incompletely folded state, but Bose concluded that StAR does its work of ushering cholesterol into the mitochondria when it is partially unfolded.

That may be because the ports that allow entry into mitochondria are very small, Bose said. "Think of a protein as a ball of spaghetti. It can only get into the mitochondria one strand at a time." A section of the protein called the "mitochondrial leader" enters a port. Inside the mitochondria, import machinery begins to pull the protein in - as if it were slurping in a strand of spaghetti. StAR unfolds to enter the port, but a compactly folded section of the protein unfolds more slowly and creates a pause in the process.

In their article for The Proceedings of the National Academy of Sciences, Bose, Miller and their colleagues propose that this flexible, "molten globule" conformation lowers the energy required for a channel to open in the mitochondrial membrane. In this form, StAR appears to function as an on/off switch for cholesterol flowing from the cell into the mitochondria. If so, it may be the first protein found that does its work in a molten globule state. More studies are necessary to determine StAR's exact structure and to work out the details of how it shepherds cholesterol into the mitochondria to be
'"/>

Contact: Janet Basu
jbasu@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
22-Jun-1999


Page: 1 2 3

Related biology news :

1. Protein is key to fatal disorder and normal cell function
2. Protein is key for digestive function of the pancreas
3. Proteins show promise for mosquito control
4. Protein involved in childhood disorder linked to cancer
5. Protein fishing in America: The movie
6. Protein vaccine fully protects mice from lethal aerosol challenge with ricin toxin
7. Protein key to trafficking in nerve terminals
8. Protein controls acid in cells by direct detection of volume changes, study finds
9. Protein believed to control formation of memory identified by Scripps & UCSD scientists
10. Protein stops blood-vessel growth, holds promise as cancer therapy
11. Proteins transform DNA into molecular velcro

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
(Date:2/1/2016)... -- Today, the first day of American Heart Month, the ... first of its kind workplace health solution that leverages ... first application of Watson to ... Welltok will create a new offering that combines AHA,s ... on Welltok,s health optimization platform. The effort is intended ...
(Date:1/25/2016)... 25, 2016  Glencoe Software, the world-leading supplier of ... industries, will provide the data management solution OMERO Plus ... Photo - ... Phenotypic analysis measures the characteristics and ... comparisons between states such as health and disease, the ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... N.C. , Feb. 5, 2016  In the ... role for a host of launch activities including the ... of this launch activity is especially high in the ... Best Practices and the Role of Medical ... help companies focused on oncology therapies find better ways ...
(Date:2/4/2016)... - New FDA action date of July 22, ... July 22, 2016   --> - ...   - Lifitegrast has the potential to be the ... signs and symptoms of dry eye disease in adults ... product approved in the U.S. in the past decade indicated for the treatment of ...
(Date:2/4/2016)... 2016  CytoSorbents Corporation (NASDAQ: CTSO ), ... CytoSorb® blood filter to treat deadly inflammation in ... announced that CEO Dr. Phillip Chan , ... Group,s 2016 Disruptive Growth & Healthcare Conference, providing ... Conference Presentation Details: Where: Convene Conference ...
(Date:2/4/2016)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") ... products in China , today announced ... received on February 4, 2016 a preliminary non-binding proposal ... of PKU V-Ming ( Shanghai ) Investment ... Development ( Shenzhen ) Fund Management Co., ...
Breaking Biology Technology:
Cached News: